(A) Laser capture microdissection (LCM) was performed to collect material from tissue resected from 45 patients. Real-time qRT-PCR was used to assess the miR-155 expression level in each sample. The relative miRNA expression was quantified using the comparative CT method (2-ΔCT). The mean value of the miR-155 expression level in these samples was used as a cut-off value to divide the patients into two groups (high or low miR-155 expression). (B) Kaplan-Meier plots of overall survival (left) and disease-free survival (right) of 23 patients according to the expression of miR-155 in their plasma exosomes (P value, log-rank test). Original images of immune blots on PVDF membrane. A membrane were cut to 6 parts at 35 kDa, and each part of membrane were separately treated from the procedure of incubation with primary antibody (TP53INP1: 27kDa, β-actin: 42kDa). Modified image to show each band more clearly were depicted in figure 3E . (A) The EC50 of GEM in Pnac1-Pt cells that were treated with exosomes isolated from PDAC cells transfected with pre-miR-155 (Panc1-OE, MiaPaCa2-OE) for 48 hours was assessed by the MTT assay (left). Apoptosis ratio was assessed in Panc1-Pt cells after GEM (50 ng/ml) treatment with or without isolated exosomes for 72 hours. The ratio of apoptotic cells was determined using the Annexin V assay (right). (B) The EC50 of GEM in MiaPaCa2-Pt cells that were treated with exosomes isolated from MiaPaCa2-OE for 48 hours was assessed by the MTT assay (left). Apoptosis ratio was assessed in MiaPaCa2-Pt cells after GEM (50 ng/ml) treatment with or without isolated exosomes for 72 hours. The ratio of apoptotic cells was determined using the Annexin V assay (right). 
